Our group uses genomic, metagenomic and cell culture approaches to understand how human microbe co-evolution shaped genetic predisposition to chronic inflammatory conditions (such as psoriasis, diabetes, and allergies). Our long-term goal is to develop novel and safe therapy based on a deeper understanding of autoimmunity biology.
